Isosorbide Dinitrate Tablet
FDA Label NDC 55154-7990

22 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Isosorbide Dinitrate (NDC 55154-7990). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, pharmacokinetics, clinical trials, indications and usage, contraindications, warnings, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-7990-0

ISOSORBIDE DINITRATE TABLETS,

USP 10 mg

10 TABLETS

10mg Bag Label (43289136 625e 4671 B4c8 Bb523c11b132 01)

10mg Bag Label (43289136 625e 4671 B4c8 Bb523c11b132 01)

NDC 55154-7991-0

ISOSORBIDE DINITRATE

TABLETS, USP 20 mg

10 TABLETS

20mg Bag Label (43289136 625e 4671 B4c8 Bb523c11b132 00)

20mg Bag Label (43289136 625e 4671 B4c8 Bb523c11b132 00)

* Please review the disclaimer below.